Isoniazid Preventive Therapy: Do the Risks Outweigh the Benefits In Pregnant Women with HIV?
Date: 03/13/2018
Publication:
aidsmap
Isoniazid preventive therapy (IPT) during and after pregnancy in women living with HIV on antiretroviral therapy (ART) in tuberculosis (TB) endemic areas in Africa, Asia and Haiti resulted in serious adverse events quite possibly attributable to isoniazid with no significant reduction in TB cases, participants heard last week at the Conference on Retroviruses and Opportunistic Infections (CROI 2018) in Boston.